Roxithromycin 150 mg - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

apo-roxithromycin

apotex pty ltd - roxithromycin -

Australia - English - Department of Health (Therapeutic Goods Administration)

chemmart roxithromycin

apotex pty ltd - roxithromycin -

Australia - English - Department of Health (Therapeutic Goods Administration)

terry white chemists roxithromycin

apotex pty ltd - roxithromycin -

Israel - English - Ministry of Health

roxo 150

unipharm ltd, israel - roxithromycin - tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Australia - English - Department of Health (Therapeutic Goods Administration)

rulide roxithromycin 300mg tablet blister pack

sanofi-aventis australia pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: purified talc; hyprolose; propylene glycol; maize starch; magnesium stearate; povidone; glucose; poloxamer; titanium dioxide; hypromellose; colloidal anhydrous silica - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: . acute pharyngitis, tonsillitis, sinusitis; . acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia; . skin and skin structure infections; . non-gonoccocal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organisms' susceptibility and thus treatment suitability. therapy with rulide may be initiated before results of these tests are known; once results become available, appropriate therapy should be considered.